Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today presented positive topline data from Part 1 of ...
Prefilled syringe offers a convenient ready-to-use administration option to healthcare professionals· Marketing authorisation in EU expected in December ...
Luxury living in the heart of the High Country – Twin Rivers Community! Welcome to your dream mountain retreat in the highly ...
NanoViricides, Inc., a publicly traded company (NYSE Amer:NNVC) (the "Company"), announced that its clinical lead drug NV-387 ...
Incyte (Nasdaq:INCY) today announced new data from the Phase 3b TRuE-AD4 study evaluating the efficacy and safety of Opzelura ® (ruxolitinib cream) in adults with moderate atopic dermatitis (AD) who ...
SHELTON, CONNECTICUT / ACCESS Newswire / October 15, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), reports that an analyst research report was published on the Company that explains ...
This trial is the first and largest study specifically designed to evaluate children and adolescents with severe alopecia areata, a population often ...
The shingles vaccine is intended to prevent shingles, but a new study suggests that it could have major secondary benefits.
Learn Travel Destinations on MSN
Ethiopian Airlines Business Class: Addis Ababa to Vienna Experience
Join me as I share my full journey flying Ethiopian Airlines Business Class from Addis Ababa to Vienna on their Boeing 787-9 ...
The China National Medical Products Administration (NMPA) has approved Shingrix (GSK's Recombinant Zoster Vaccine or RZV) for ...
A recent study shows adults with cardiovascular disease (CVD) have a higher risk of developing shingles. Shingles is caused ...
Sunspot AR4618 erupted with an M4.4-class solar flare causing a coronal mass ejection (CME) that may give Earth a glancing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback